Home
Browse All Titles
Sign In
Browse All Titles
Targeted Cancer Therapy A Handbook for Nurses
About
Table of Contents
Main Index
Figure(s)
Table(s)
Search
GoogleAnalytics
All Resources
Current Resource
Go
i
https://webview.skyscape.com
◀
*
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Z
▶
View All
Vadimeza (Novartis)
Antiangiogenic Drug Therapy
Hypoxia-Inducible Factor, Mtor, and Angiogenesis
Vandetanib (D6474, Zactima, investigational)
adverse reactions
Antiangiogenic Drug Therapy
class
dosage, reconstitution, and administration
mechanism of action
Nursing Considerations and Drug Information
Vascular-disrupting agents
Antiangiogenic Drug Therapy
Chapter 2. Targeted Cancer Therapy: External and Internal Signaling Pathway Targets
Hypoxia-Inducible Factor, Mtor, and Angiogenesis
References (Chapter 3)
Tumor Vasculature and Microenvironment
Vascular endothelial cells
Vascular endothelial growth factor
Application Of The Hallmarks Of Cancer
bevacizumab targets and
Bone Metastasis
Glossary
inhibitors
Invasion and Metastasis
MAbs directed against
neutralizing
References (Chapter 3)
signaling
Targeting Angiogenesis
Vatalanib (PTK787/ZK222584, investigational)
adverse reactions
class
dosage, reconstitution, and administration
mechanism of action
metabolism
Nursing Considerations and Drug Information
VDAs,
Vectibix,
VEGF,
VEGF-A
Antiangiogenic Drug Therapy
Glossary
Hypoxia-Inducible Factor, Mtor, and Angiogenesis
Invasion and Metastasis
Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways)
Nursing Considerations and Drug Information
Protein Dynamics: Heat Shock Proteins and Ubiquitin - Proteasome Inhibitors
Targeting Angiogenesis
Tumor Vasculature and Microenvironment
VEGF-B
Glossary
Nursing Considerations and Drug Information
Targeting Angiogenesis
VEGF-C
Glossary
Hypoxia-Inducible Factor, Mtor, and Angiogenesis
Targeting Angiogenesis
VEGF-D
Nursing Considerations and Drug Information
References (Chapter 3)
Targeting Angiogenesis
VEGF inhibitors
VEGFR-1
Antiangiogenic Drug Therapy
Nursing Considerations and Drug Information
Targeting Angiogenesis
VEGFR-2
Antiangiogenic Drug Therapy
Mitotic Kinase Inhibitors
Nursing Considerations and Drug Information
References (Chapter 2)
Targeting Angiogenesis
VEGF receptor (VEGFR)
Velcade,
Epigenetics
Summary
Verapamil
Drug Interactions: Focus On The P450 Microenzyme System
Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways)
Nursing Considerations and Drug Information
References (Chapter 3)
Vesanoid,
VHL gene,
Vidaza,
Vinorelbine, gefitinib coadministered with
Vitamin D
Bone Metastasis
Drug Interactions: Focus On The P450 Microenzyme System
Pharmacologic Management
Protein Kinase Signaling Pathways
References (Chapter 2)
Vitamin K, EGFR function in skin and
von Hippel-Lindau protein
Antiangiogenic Drug Therapy
Hypoxia-Inducible Factor, Mtor, and Angiogenesis
von Hippel-Lindau tumor suppressor gene
Application Of The Hallmarks Of Cancer
Insulin-Like Growth Factor Receptor Pathway Targets
Intracellular Signaling Kinases (E.g., Src, P13k/Akt/Mtor; Mapk; Sonic Hedgehog Pathways)
Vorinostat (Zolinza)
V-sis
Refresh
first
prev
1
30
select
next
last
Displaying items 1 - 30 of 30